Empagliflozin (brand name: Jardiance) is a sodium glucose co-transporter 2 (SGLT2) inhibitor with important benefits for patients with type 2 diabetes and concomitant heart failure, cardiovascular disease (CVD) or renal disease
At each step in the process, a specific liver enzyme a protein that speeds up a process within cells is used to convert one form of the drug into another, until endoxifen is formed (see diagram)
With just 70 calories per serving, its easy to incorporate into coffee, smoothies, or water for a clean daily boost
Disease Prevention Cardiovascular disease Choline and homocysteine A large body of research indicates that even moderately elevated levels of homocysteine in the blood increase the risk of cardiovascular disease (11)
Semaglutide and tirzepatide are injectable medications initially developed to treat Type 2 diabetes
BPC-157 alongside joint PRP therapy